Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837421 · ClinicalTrials.gov registry record
The Ohio State University Sepsis Registry
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 230
- Enrollment target
NCT00837421: Clinical Trial study, sponsored by Ohio State University.
NCT00837421 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 230 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00837421 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 230 participants
- Enrollment target
Study Summary
Specific Aim #1: To collect follow-up information about patients with sepsis in the OSUMC MICU who survive to hospital discharge for future retrospective IRB-approved studies. Specific Aim #2: To collect a registry of patients who would be interested in hearing more information about future prospective IRB-approved studies for survivors of sepsis. Specific Aim #3: To collect a blood sample from patients with sepsis admitted to the OSUMC MICU for future retrospective IRB-approved studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2006-12 |
| Est. Completion | 2011-11 |
Why NCT00837421 stopped before completion
NCT00837421 is an observational study that tracks outcomes without assigning an intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00837421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00837421 about?
NCT00837421 is a clinical study titled "The Ohio State University Sepsis Registry". Specific Aim #1: To collect follow-up information about patients with sepsis in the OSUMC MICU who survive to hospital discharge for future retrospective IRB-approved studies. Specific Aim #2: To collect a registry of patients who would be interested in hearing more information about future prospec...
What is the current status of trial NCT00837421?
This trial is currently terminated. The enrollment target is 230 participants. The study started on 2006-12. Estimated completion is 2011-11.
Who is sponsoring clinical trial NCT00837421?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia